Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase
- 49 Downloads
Correction to: Arch. Pharm. Res. (2018) 41:196–207 https://doi.org/10.1007/s12272-017-0999-6
The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as:
Conflict of interest
The authors declare no conflict of interest.
© The Pharmaceutical Society of Korea 2019